Objectives: Phosphate and tensin homolog gene (PTEN) acts as a regulator of P13-K-Akt molecular pathway. ETS Related gene (ERG), an oncogene located in chromosome 2Iq22.2, is involved in prostate cancer (PCa) by serine 2 (TMPRSS2), a protein encoded by TMPRSS2 gene. The aim of this study is to evaluate the clinical impact oj PTEN loss and ERG rearrangement in terms of oncologic results in patients diagnosed with localized PCa who underwent radical prostatectomy. Materials and methods: Prospective data were collected from a total of 74 patients who underwent open radical retropubic prostatectomy for localized PCa and immunohistochemical study was performed in tissue samples. The primary antibodies for anti-ERG antibody as well as anti-PTEN a...
TMPRSS2–ERG is the most frequent type of genomic rearrangement present in prostate tumors, in which ...
Haijie Xie, Bin Xie, Chunyu Liu, Jun Wang, Yong Xu Department of Urology, Tianjin Institute of Urol...
The second most prevalent cancer among men with a 5-year survival rate of 30%, prostate cancer is a ...
We have previously demonstrated a significant correlative relationship between PTEN deletion and ERG...
Purpose: The aim of our study was to observe the associations between the ETS-related gene (ERG) and...
in prostate cancer (PC) and evaluate their prognostic significance. Despite conflicting published r...
Background Active surveillance (AS) is an option for men with low-risk prostate cancer (PCa). PTEN a...
Background Phosphatase and tensin homolog (PTEN) gene aberration and trans membrane protease, serine...
Recently, ETS-related gene (ERG) gene rearrangements, phosphatase tensin homologue (PTEN) deletions ...
OBJECTIVES: To assess the prognostic value of ERG and PTEN protein expression as two of the most com...
none19siFirst published online November 27, 2015BACKGROUND: PTEN is a tumor suppressor frequently...
© 2017, Spandidos Publications. All rights reserved. The oncogene ETS-related gene (ERG) encodes a t...
none23siBACKGROUND: Whether the genomic rearrangement transmembrane protease, serine 2 (TMPRSS2):...
Prostate cancer (PrCa) is a highly heterogeneous disease and its prognosis, diagnosis and management...
Prostate cancer (PC) is one of the most common neoplasms in men around the world. Current tools avai...
TMPRSS2–ERG is the most frequent type of genomic rearrangement present in prostate tumors, in which ...
Haijie Xie, Bin Xie, Chunyu Liu, Jun Wang, Yong Xu Department of Urology, Tianjin Institute of Urol...
The second most prevalent cancer among men with a 5-year survival rate of 30%, prostate cancer is a ...
We have previously demonstrated a significant correlative relationship between PTEN deletion and ERG...
Purpose: The aim of our study was to observe the associations between the ETS-related gene (ERG) and...
in prostate cancer (PC) and evaluate their prognostic significance. Despite conflicting published r...
Background Active surveillance (AS) is an option for men with low-risk prostate cancer (PCa). PTEN a...
Background Phosphatase and tensin homolog (PTEN) gene aberration and trans membrane protease, serine...
Recently, ETS-related gene (ERG) gene rearrangements, phosphatase tensin homologue (PTEN) deletions ...
OBJECTIVES: To assess the prognostic value of ERG and PTEN protein expression as two of the most com...
none19siFirst published online November 27, 2015BACKGROUND: PTEN is a tumor suppressor frequently...
© 2017, Spandidos Publications. All rights reserved. The oncogene ETS-related gene (ERG) encodes a t...
none23siBACKGROUND: Whether the genomic rearrangement transmembrane protease, serine 2 (TMPRSS2):...
Prostate cancer (PrCa) is a highly heterogeneous disease and its prognosis, diagnosis and management...
Prostate cancer (PC) is one of the most common neoplasms in men around the world. Current tools avai...
TMPRSS2–ERG is the most frequent type of genomic rearrangement present in prostate tumors, in which ...
Haijie Xie, Bin Xie, Chunyu Liu, Jun Wang, Yong Xu Department of Urology, Tianjin Institute of Urol...
The second most prevalent cancer among men with a 5-year survival rate of 30%, prostate cancer is a ...